Option chain shows key data for Pasithea Therapeutics's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Pasithea Therapeutics.

Pasithea Therapeutics (NASDAQ:KTTA) Stock, Option Chain

Pasithea Therapeutics

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia.

Prague,cz,-27,April,2023:,Logo,On,Accenture,Headquarters,In,Prague.

Earnings

Equities

News

Eurozone

Commodities

Markets

Trading Ideas

CNXC

KTTA

MDXH

RYDE

TBIO

Dow Surges Over 250 Points; Accenture Earnings Top Views

Crude-oil-4-logo

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Intraday Update

ADPT

Crude Oil Down Over 2%; US Initial Jobless Claims Fall

Wall Street

VSME

Nasdaq Gains Over 1%; Micron Posts Upbeat Q4 Results

Pasithea Therapeutics Corp. - Common Stock

Pasithea Therapeutics Corp

Major players in the digital asset industry are vying for positions on President-elect Donald Trump&#8216;s <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42098407/donald-trump-reportedly-eyeing-the-first-crypto-focused-role-in-the-white-house">promised crypto advisory council.</a>
According to Reuters, companies such as Ripple (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>), Kraken and Circle (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">USDC</a>) are among those seeking representation on the council, which Trump pledged to establish as part of his crypto-friendly administration. 
The transition team is currently deliberating on the council&#8217;s structure, staffing and composition.
David Bailey, CEO of Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) Magazine, who arranged Trump&#8217;s speech at a July bitcoin conference, told Reuters, &#8220;It&#8217;s being fleshed out, but I anticipate the leading executives from America&#8217;s bitcoin and crypto firms to be represented.&#8221; 
Bailey added, &#8220;People are eager to advise and give input.&#8221;
The council is expected to be housed under the White House&#8217;s National Economic Council or a separate White House apparatus. 
Its responsibilities may include advising on digital asset policy, collaborating with Congress on crypto legislation, establishing <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42121376/strategic-bitcoin-reserve-wouldnt-require-new-taxpayer-dollars-says-sen-cynthia-lummis">Trump&#8217;s promised bitcoin reserve</a>, and coordinating between regulatory agencies.
Some notable figures have already engaged with the incoming administration. 
Coinbase (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">COIN</a>) CEO Brian Armstrong recently <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42052797/trump-and-coinbase-ceo-brian-armstrong-reportedly-in-talks-over-cabinet-appointments">met with Trump</a>, though the details of their discussion remain undisclosed. 
Circle CEO Jeremy Allaire has publicly expressed interest in joining <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42114875/coinbase-ceo-brian-armstrong-stands-out-as-candidate-for-donald-trumps-reported-crypto-czar-position-cardano-co-founder-says">the council.</a>
The industry&#8217;s enthusiasm for a crypto-friendly Trump administration has contributed to Bitcoin&#8217;s recent surge toward the <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42120005/bitcoin-close-to-100000-could-it-happen-today" target="_blank" rel="noopener">$100,000 milestone</a>.
Trump&#8217;s campaign promises included becoming a &#8220;<a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41770352/bitcoins-future-under-president-elect-donald-trump-a-look-at-his-crypto-policies">crypto president</a>&#8221; and ending the Biden administration&#8217;s <a href="https://www.benzinga.com/news/legal/24/11/41996491/18-republican-states-sue-bidens-sec-over-harsh-crypto-crackdown">regulatory crackdown</a> on crypto companies.
Read Next: <a href="https://www.benzinga.com/general/social-media/24/11/42119493/rumble-eyes-buying-bitcoin-could-it-be-the-next-microstrategy">Rumble CEO Considers Bitcoin Investment, Engages Michael Saylor As Shares Rally</a>
Why It Matters: The formation of this council is not without controversy. 
Some consumer groups have cautioned against allowing the crypto industry to write its own rules. 
Nathan McCauley, CEO of Anchorage Digital, defended the approach, telling Reuters, &#8220;It&#8217;s absolutely the wise choice to put together a council of people who… understand how both the industry ought to be regulated and how to situate the industry to be a strategic asset.&#8221;
The news comes on the same day SEC Chair Gary Gensler <a href="https://www.benzinga.com/government/regulations/24/11/42120607/gary-gensler-to-step-down-as-sec-chair-on-trumps-inauguration-day">announced his resignation</a> on Jan. 20, 2025.
Gensler has repeatedly described the cryptocurrency as the&nbsp;<a href="https://www.benzinga.com/markets/cryptocurrency/23/12/36358607/crypto-wild-west-hurts-investors-sec-chair-says-bankruptcy-court-queues-are-crowded" target="_blank" rel="noreferrer noopener">"Wild West,&#8221;</a> drawing the ire of industry participants over a&nbsp;<a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41993524/gary-gensler-hints-at-ending-his-stint-as-sec-chair-defends-crypto-regulation-agenda" target="_blank" rel="noreferrer noopener">stringent regulatory approach</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/movers/24/11/41949068/bitcoin-could-reach-1-million-by-2037-economist-says-buy-of-a-lifetime-opportunity">Bitcoin Could Reach $1 Million By 2037, Economist Says: ‘Buy Of A Lifetime' Opportunity</a></li>
</ul>
Image: Shutterstock

$BTC

$COIN

$USDC

$XRP

Trump's Planned Crypto Council May Oversee Bitcoin Reserve: Report

MKZR

MacKenzie Realty Capital Q1 EPS $(0.61), Net Revenues $5M

A 2,000-year-old Egyptian mug, known as a Bes mug, was used to consume a potent concoction of <a href="https://www.benzinga.com/markets/psychedelics">psychedelic substances</a>, alcohol and human bodily fluids, according to new research. The <a href="https://www.nature.com/articles/s41598-024-78721-8">study</a>, published in Scientific Reports, utilized advanced chemical and DNA analysis to uncover the complex composition of the mug&#8217;s last contents.
<h4 class="wp-block-heading">The Mug And Its Mythical Connection</h4>
The artifact, housed at the Tampa Museum of Art, features the head of Bes, an Egyptian deity linked to protection, fertility and joy. During the Ptolemaic period (330–30 BCE), Bes also took on mystical and oracular roles, often associated with transformative rituals.
Researchers analyzed residues scraped from the inner walls of the mug and identified psychoactive substances such as Peganum harmala (Syrian rue) and Nymphaea caerulea (blue water lily). Syrian rue contains alkaloids like harmine and harmaline, known for inducing dream-like visions, while blue water lily is linked to mild sedative and euphoric effects.
<h4 class="wp-block-heading">Ritual And Symbolism</h4>
Researchers said the mug was used in fertility-related rituals reenacting Egyptian myths. &#8220;These substances reveal the sophistication of ancient Egyptian ritual practices,&#8221; <a href="https://www.newsweek.com/ancient-egyptians-drank-cocktail-psychedelic-body-fluid-alcohol-1987914">said</a> study author Enrico Greco to Newsweek. &#8220;Their use highlights a deliberate attempt to connect with the divine through physical and spiritual transformation.&#8221;
In addition to <a href="https://www.benzinga.com/markets/cannabis/22/02/25568274/entheogens-and-plant-medicine-an-introduction">psychoactive plants</a>, the mixture contained fermented alcoholic liquids, honey, sesame seeds, pine nuts, licorice and grapes. Unexpectedly, the analysis also revealed proteins from human bodily fluids such as blood, vaginal mucus and breast milk, which Greco described as &#8220;highly symbolic elements emphasizing themes of life, fertility, and regeneration.&#8221;
<h4 class="wp-block-heading">Advanced Analysis Techniques</h4>
&#8220;This is the first comprehensive scientific analysis of a Bes mug&#8217;s organic residues,&#8221; explained Davide Tanasi, lead author from the University of South Florida. &#8220;For the first time, we were able to identify all the chemical signatures of the components of the liquid concoction.&#8221;
The study underscores the Egyptians&#8217; advanced understanding of natural resources and their effects on the human mind. &#8220;The identified substances likely induced dream-like visions, heightened meditative states, and possibly euphoria,&#8221; said Greco.
<h4 class="wp-block-heading">Expanding Understanding Of Egyptian Rituals</h4>
The Bes mug was not merely decorative or utilitarian but played a critical role in complex ceremonial practices. The findings provide tangible evidence of how ancient Egyptians used psychotropic substances to achieve altered states of consciousness in rituals involving fertility, prophecy, and spiritual transformation.
&#8220;This study reveals that Bes mugs were more than decorative—they were integral to mystical and ritualistic practices,&#8221; Greco concluded.
Cover image made with AI

Cannabis

Psychedelics

Study Reveals Psychedelic Ritual Cocktail In Ancient Egyptian Mug

XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>) is up 8% over the past 24 hours, gaining momentum as news of SEC Chairman <a href="https://www.benzinga.com/government/regulations/24/11/42120607/gary-gensler-to-step-down-as-sec-chair-on-trumps-inauguration-day">Gary Gensler stepping down</a> sends bullish signals across the market.
What Happened: Gensler announced his resignation effective January 20, 2025, which has been interpreted as a positive development for Ripple.
XRP's price surged 8% on Thursday, contributing to a 51% gain over the past week and a remarkable 120.2% increase over the past month.
This development is seen as a turning point for Ripple and its associated cryptocurrency, XRP, amid its ongoing legal battles with the SEC.
Statistics: CryptoQuant Korea observed a significant rise in XRP deposits on Binance, primarily driven by retail traders. 
This <a href="https://x.com/CryptoQuant_KR/status/1859383038028943864">marks</a> the end of an 18-month trend of consistent withdrawals. 
The 30-day moving average revealed a net inflow of 470 transactions, the highest influx in nearly two years.
Trader Notes: Crypto chart analyst Ali Martinez described Gensler's resignation as "the best thing that could happen to Ripple" and set a price target of $2 for XRP.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">‘<a href="https://twitter.com/GaryGensler?ref_src=twsrc%5Etfw">@GaryGensler</a> leaving the <a href="https://twitter.com/SECGov?ref_src=twsrc%5Etfw">@SECGov</a> is the best thing that could happen to <a href="https://twitter.com/Ripple?ref_src=twsrc%5Etfw">@Ripple</a>. Now, <a href="https://twitter.com/search?q=%24XRP&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$XRP</a> targets $2! <a href="https://t.co/YEDiZtrnB1">https://t.co/YEDiZtrnB1</a> <a href="https://t.co/LLE4n0MC8z">pic.twitter.com/LLE4n0MC8z</a>
&mdash; Ali (@ali_charts) <a href="https://twitter.com/ali_charts/status/1859661298931466612?ref_src=twsrc%5Etfw">November 21, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
DonAlt praised XRP's price action, <a href="https://x.com/CryptoDonAlt/status/1859663970296267126">expressing</a> confidence in a breakout above $0.70 resistance, with a forecasted next stop at $1.6. In a lighter tone, he joked, "ETH flips BTC, XRP flips ETH, everything implodes."
CrediBULL Crypto predicted XRP would achieve a new all-time high "quicker than most expect," projecting outperformance against Bitcoin and Ethereum.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">I think <a href="https://twitter.com/search?q=%24XRP&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$XRP</a> is probably going to make new ATH a lot quicker than most are expecting- and I think it&#39;s going to vastly outperform both <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> and <a href="https://twitter.com/search?q=%24ETH&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$ETH</a> from current levels while doing it. XRP/ETH just reclaimed and retested a 4 year long range, with the first target being ~250%… <a href="https://t.co/fLYlH2GEYB">pic.twitter.com/fLYlH2GEYB</a>
&mdash; CrediBULL Crypto (@CredibleCrypto) <a href="https://twitter.com/CredibleCrypto/status/1859581839637446946?ref_src=twsrc%5Etfw">November 21, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42011875/solana-ripple-litecoin-etfs-may-be-on-the-table-under-trump-administration-industry-experts-think">Solana, Ripple, Litecoin ETFs May Be On The Table Under Trump Administration, Industry Experts Say</a></li>
</ul>
Image: Shutterstock

XRP Price Up 8%: What Is Going On With Ripple?

Summit Materials Confirms Receipt Of Non-Binding Acquisition Proposal And Initial Discussions With Interested Party, Names Morgan Stanley And Evercore As Advisors

Nintendo ADR&#8216;s (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NTDOY#OTC">NTDOY</a>) Pokémon TCG Pocket, a<a href="https://www.benzinga.com/topic/mobile-gaming"> mobile game</a> that combines the collectible card game experience with a free-to-play model, has made waves with its<a href="https://www.benzinga.com/general/gaming"> pricing structure. </a>
Gamer and Reddit user Weens4Life has shared how they spent $1,500 to complete the Genetic Apex set—a task that involved opening 1,741 booster packs to obtain all the cards, <a href="https://www.ign.com/articles/pokmon-tcg-pocket-player-reveals-exactly-how-long-it-takes-to-complete-the-first-set-after-spending-1500">according </a>to IGN.
See Also: <a href="https://www.benzinga.com/general/gaming/24/11/42046762/the-game-awards-2024-nominees-are-here-dlc-and-remakes-make-the-list">The Game Awards 2024 Nominees Are Here: DLC And Remakes Make The List</a>
The set, which contains 286 cards, includes 226 base cards and 60 alternate art &#8220;secret&#8221; cards that are much harder to get. While completing the base set of 226 cards cost about $200, collecting the alternate art cards was far more expensive. Weens4Life spent between $500 and $700 just to collect the final three alternate art cards.
&#8220;It was worth it to me,&#8221;said Weens4Life. But he added: &#8220;For future packs I will only be collecting the base set though.&#8221;
<h3 class="wp-block-heading">The Free-To-Play Grind</h3>
While the game is free to play, the rewards are not easy to come by. In the beginning, players receive many booster packs, but the amount drops off quickly. Eventually, players can only earn two packs per day during lulls between events. For players who want to progress faster, spending money is almost necessary.
Weens4Life used the Wonder Pick feature to get more cards, but this method offers only a 20% chance to pull a desired card, making it an unreliable choice. 
They ended up opening 8,582 packs, which included 129 Slowpoke cards and nine rare Mewtwo cards. Despite the large number of packs, they never pulled a "god pack," a rare event where players get a full set of the most coveted cards in one go.
<h3 class="wp-block-heading">Future Sets And Continuous Content</h3>
Creatures Inc., the developer behind Pokémon TCG Pocket, plans to keep the game fresh with more card sets. The company has confirmed that a smaller card drop is coming in December, followed by a full set in January. 
This means that players who completed Genetic Apex will face another round of card collecting, and those still working through the set will have new cards to chase.
In its first three weeks, the game earned $120 million and had 30 million downloads<a href="https://www.benzinga.com/general/gaming/24/11/41725114/pok-mon-tcg-pocket-earns-12-million-in-four-days-fueled-by-u-s-downloads"> after just nine days. </a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/gaming/24/11/42118521/xbox-cloud-gaming-now-lets-you-stream-owned-games-heres-how-it-works">Xbox Cloud Gaming Now Lets You Stream Owned Games: Here&#8217;s How It Works</a></li>
</ul>
Image credits: Shutterstock.

Gaming

NTDOY

How Much Does It Really Cost To Complete Pokémon TCG's First Set?

Buybacks

CVBF

CVB Financial Corp. Authorizes 10M Share Repurchase Plan

Donald Trump's election stoked anticipation of a looser regulatory landscape, benefiting the crypto ecosystem. 
Companies like MicroStrategy Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>), long synonymous with its audacious Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) strategy, is emerging as a key player in this evolving market. 
The company, which owns more than 150,000 Bitcoin, effectively operates as a leveraged bet on the cryptocurrency. Its <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/05/39045022/microstrategys-big-move-from-bitcoin-bet-to-russell-1000-inclusion">inclusion in equity indices</a> has quietly exposed countless institutional and retail investors to Bitcoin's wild price swings, even if they never intended to dabble in crypto.
As Bitcoin <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42107053/mstr-climbs-over-8-in-thursday-pre-market-as-bitcoin-approaches-98000-michael-saylors-company-has-more-than-doubled-the-investors-wealth-since-trumps-victory">rallied post-election</a> on optimism about regulatory clarity, MicroStrategy shares surged, highlighting the close correlation. 
Meanwhile, the broader crypto industry is buzzing with new ventures from Wall Street to Silicon Valley.
<h2 class="wp-block-heading">Crypto Initiatives Gain Traction</h2>
JPMorgan Chase is currently <a href="https://www.jpmorgan.com/insights/payments/payment-trends/introducing-kinexys">rebranding</a> its blockchain platform from Onyx to Kinexys, and aims to transform foreign exchange markets, according to Nikolaos Panigirtzoglou, an analyst with the firm. 
Goldman Sachs is also carving out its <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42047066/goldman-sachs-to-spin-out-digital-assets-platform-amid-blockchain-push">digital asset division</a> to expand private blockchain services. And BlackRock is doubling down with a <a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39863203/blackrocks-buidl-tokenization-fund-hits-500m-in-assets-under-management">tokenized money market fund</a> on diverse blockchains, signaling a strategic shift.
These developments underline the growing institutional appetite for blockchain, from tokenized treasuries in El Salvador to cutting-edge trade finance solutions in Brazil.
Read Also: <a href="https://www.benzinga.com/news/events/24/11/42012198/a-new-era-how-tokenization-could-reduce-frictions-and-potentially-costs-in-finance">A New Era? How Tokenization Could &#8216;Reduce Frictions And Potentially Costs&#8217; In Finance</a>
<h2 class="wp-block-heading">MicroStrategy's Big Bet: A Tailwind Or A Trap?</h2>
MicroStrategy's role as a Bitcoin proxy has drawn mixed reactions. Some view it as a savvy way to capitalize on crypto's growth; others worry about overexposure to Bitcoin's volatility. Yet, as the Leveraged MicroStrategy ETF (Defiance Daily Target 2x Long MSTR ETF (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mstx#NASDAQ">MSTX</a>) <a href="https://www.globenewswire.com/news-release/2024/11/12/2979763/0/en/MSTX-The-First-Leveraged-MicroStrategy-ETF-Surpasses-1-Billion.html">gains inflows</a> and demand for Bitcoin ETFs surges, the company's strategy looks increasingly prescient.
Panigirtzoglou, in a Thursday analyst report, highlighted a burgeoning trend: corporate treasuries are dipping their toes into Bitcoin as a reserve asset. If this is the start of a trend, MicroStrategy is ahead of the curve.
With Bitcoin at the heart of a post-election crypto surge, MicroStrategy's bold approach positions it as both a leader and a litmus test for the future of corporate crypto adoption. Whether it rides this wave to unprecedented highs or succumbs to volatility will depend as much on regulatory clarity as on the trajectory of Bitcoin itself.
In a rapidly transforming market, one thing is clear: MicroStrategy's &#8220;leveraged bet on Bitcoin&#8221; makes it a stock to watch in this new crypto-driven era.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/ipos/24/11/42068551/nexbridge-brings-bitcoin-tech-to-us-treasury-bills-tokenized-exposure-anyone">NexBridge Brings Bitcoin Tech To US Treasury Bills: Tokenized Exposure, Anyone?</a></li>
</ul>
Image: Shutterstock

MSTR

MSTX

Bitcoin Boom 2.0? MicroStrategy Gains Traction As 'Leveraged Bet' On Crypto Growth

Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>) is up 20% to $258.55 over the past week, driven by broader crypto market strength. Bitcoin's rally past $98,000 and the speculation that it <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42120005/bitcoin-close-to-100000-could-it-happen-today">could cross $100,000</a> have lifted sentiment for the entire crypto sector, with Solana standing out as a high-performance blockchain platform.
What To Know: Solana is known as a go-to platform for developers, surpassing several competitors in scalability and transaction efficiency. Its growth has been supported by partnerships and <a href="https://www.benzinga.com/money/how-to-buy-solana">ecosystem developments</a>, including new DeFi protocols and NFT marketplaces launching on the network.
Additionally, Solana's improved resilience, following earlier network outages, is <a href="https://www.benzinga.com/money/solana-price-prediction">rebuilding investor confidence</a>. The network's upgrades, such as validator optimizations, have enhanced its reliability.
The broader crypto market also plays a significant role in Solana's rally. Institutional activity, such as the $1.84 billion inflow into Bitcoin ETFs, has highlighted increasing demand for digital assets of late. Solana, often viewed as an alternative to Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>), is benefiting from the bullish outlook across major cryptocurrencies.
With speculation that Solana could break $275 this month, as suggested by <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42114012/bitcoin-price-hitting-100000-in-november-polymarket-traders-speculate-it-might-go-even-higher">Polymarket bettors</a>, the blockchain's combination of speed, utility and ecosystem growth is catching eyes during the broader crypto rally.
Read Also: <a href="https://www.benzinga.com/economics/macro-economic-events/24/11/42121049/small-caps-rally-alphabet-plummets-bitcoin-flirts-with-100000-whats-driving-markets-thursday">Small Caps Rally, Alphabet Plummets, Bitcoin Flirts With $100,000: What&#8217;s Driving Markets Thursday?</a>

$ETH

$SOL

Why Solana Is Up 20% Over The Past Week

Litecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/ltc/usd">LTC</a>) has surged 8.9% to $89.59 over the past week, benefiting from a wave of positive sentiment sweeping the <a href="https://www.benzinga.com/crypto">cryptocurrency</a> market. 
This uptick comes as Bitcoin approaches the $100,000 milestone, which has significantly boosted investor confidence across the digital asset landscape.
What To Know: Polymarket bettors are closely watching Bitcoin's trajectory this November, with a <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42114012/bitcoin-price-hitting-100000-in-november-polymarket-traders-speculate-it-might-go-even-higher">79% probability of surpassing $100,000</a>. This bullish outlook on Bitcoin has a cascading effect on altcoins like Litecoin, which often mirrors Bitcoin's market movements. 
The anticipation of Bitcoin reaching new heights has attracted substantial institutional interest, further enhancing market optimism.
Read Also: <a href="https://www.benzinga.com/news/24/11/42116978/why-bitcoin-cash-is-up-15-this-week">Why Bitcoin Cash Is Up 15% This Week</a>
Additionally, the recent influx of $1.84 billion into U.S. Bitcoin spot ETFs over the past three days underscores growing institutional trust in cryptocurrencies. This surge in ETF inflows not only supports Bitcoin but also provides liquidity that benefits the broader crypto ecosystem, including Litecoin.
As investors seek diversification within the crypto space, Litecoin's reputation as an alternative to Bitcoin may make it an attractive option.
Read Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42120005/bitcoin-close-to-100000-could-it-happen-today">Bitcoin Close To $100,000 — Could It Happen Today?</a>

$LTC

Why Litecoin Is Moving

Global-E Online Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLBE#NASDAQ">GLBE</a>) reported better-than-expected third-quarter results and <a href="https://www.benzinga.com/quote/GLBE/earnings">raised its FY24 outlook on Wednesday.</a>
Sales grew 32% year over year to $176 million, beating the analyst consensus estimate of $169.16 million.
Adjusted EBITDA rose to $31.1 million from $22.1 million a year ago. The company's operating loss narrowed to $21.0 million from $35.6 million. Loss per share was 13 cents, beating the consensus loss of 15 cents.
For the fourth quarter, Global-e Online projects GMV of $1.615 billion – $1.685 billion and revenue of $243 million and $255 million vs. $246.27 million estimate. The company raised its FY24 revenue guidance to $732.9 million&nbsp; – $744.9 million (from $710 million – $750 million), vs. the consensus of $730.72 million.
Founder and CEO Amir Schlachet said, "We report today the results of another very strong quarter, with growth of GMV accelerating to 35% year over year and many new merchants going live ahead of the holiday season, including the iconic luxury department store Harrods."
Global-E Online shares gained 4% to trade at $49.78 on Thursday.
These analysts made changes to their price targets on Global-E Online following earnings announcement.
<ul>
<li>Piper Sandler analyst Brent Bracelin reiterated Global E Online with an Overweight and raised the price target from $44 to $63.</li>
<li>JMP Securities analyst Patrick Walravens maintained the stock with a Market Outperform and raised the price target from $46 to $64.</li>
<li>Benchmark analyst Mark Zgutowicz maintained the stock with a Buy and raised the price target from $45 to $60.</li>
<li>Wells Fargo analyst Andrew Bauch maintained the stock with an Overweight rating and increased the price target from $45 to $60.</li>
<li>Raymond James analyst Brian Peterson maintained Global E Online with an Outperform rating and boosted the price target from $41 to $55.</li>
</ul>
Considering buying GLBE stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="540" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21143119/image-231-1024x540.png" alt="" class="wp-image-659669" style="width:615px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21143119/image-231-1024x540.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21143119/image-231-300x158.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21143119/image-231-768x405.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21143119/image-231.png 1237w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/24/11/42117130/this-palo-alto-networks-analyst-turns-bullish-here-are-top-5-upgrades-for-thursday">This Palo Alto Networks Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday</a></li>
</ul>

Price Target

Analyst Ratings

GLBE

These Analysts Raise Their Forecasts On Global-E Online Following Better-Than-Expected Results

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining by more than 500 points on Thursday.
The Dow traded up 1.24% to 43,945.57 while the NASDAQ rose 0.09% to 18,982.36. The S&amp;P 500 also rose, gaining, 0.62% to 5,953.83.
Check This Out: <a href="https://www.benzinga.com/24/11/42086207/jim-cramer-likes-devon-energy-but-says-this-energy-stock-is-far-superior-to-devon">Jim Cramer Likes Devon Energy, But Calls Another Stock &#8216;Far Superior</a>&#8216;
Leading and Lagging Sectors Energy shares rose by 1.6% on Thursday.
In trading on Thursday, communication services shares fell by 2.3%.
Top Headline
Shares of Baidu, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>) fell more than 5% on Thursday after the company reported results for its fiscal third quarter.
The company posted quarterly revenue of $4.78 billion, down 3% year-on-year, topping the analyst consensus estimate of $4.69 billion. Baidu's adjusted earnings per ADS of $2.37 beat the analyst consensus estimate of $2.35.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Quantum Computing Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUBT#NASDAQ">QUBT</a>) shares shot up 29% to $4.75. Quantum Computing announced it received another purchase order for its photonic chip foundry.</li>
<li>Shares of Snowflake Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>) got a boost, surging 32% to $170.79 after the company reported stronger-than-expected results for its third quarter. Snowflake expects fourth-quarter product revenue in the range of $906 million to $911 million, up approximately 23% year-over-year. The company also raised its full-year product revenue guidance from $3.356 billion to $3.43 billion, representing 29% year-over-year growth.</li>
<li>Universal Technical Institute, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UTI#NYSE">UTI</a>) shares were also up, gaining 19% to $23.71 after the company posted upbeat quarterly earnings.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Cool Company Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLCO#NYSE">CLCO</a>) shares dropped 13% to $9.27 following third-quarter results.</li>
<li>Shares of Pyxis Oncology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYXS#NASDAQ">PYXS</a>) were down 44% to $2.14 after the company announced PYX-201 clinical Phase 1 part 1 data.</li>
<li>Kura Oncology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KURA#NASDAQ">KURA</a>) was down, falling 34% to $10.46. Kura Oncology and Kyowa Kirin disclosed a global strategic collaboration to develop and commercialize Ziftomenib in Acute Leukemias.</li>
</ul>
Commodities In commodity news, oil traded up 1.7% to $70.06 while gold traded up 0.8% at $2,673.60.
Silver traded down 0.3% to $30.920 on Thursday, while copper fell 0.9% to $4.1170.
Euro zone
European shares closed higher today. The eurozone's STOXX 600 rose 0.41%, Germany's DAX gained 0.74% and France's CAC 40 rose 0.21%. Spain's IBEX 35 Index rose 0.19%, while London's FTSE 100 gained 0.79%.
Consumer confidence in the Eurozone fell by 1.2 points to a reading of -13.7 in November.
Asia Pacific Markets
Asian markets closed mostly lower on Thursday, with Japan's Nikkei 225 falling 0.85%, Hong Kong's Hang Seng Index falling 0.53%, China's Shanghai Composite Index gaining 0.07% and India's BSE Sensex falling 0.54%.
Economics
<ul>
<li>U.S. existing home sales gained by 3.5% from the previous month to an annualized rate of 3.96 million in October.</li>
<li>The Philadelphia Fed Manufacturing Index fell to -5.5 in November from 10.3 in the previous month, and compared to market estimates of 8.</li>
<li>U.S. initial jobless claims declined by 6,000 from the previous week to 213,000 in the week ending Nov. 16.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/24/11/42112636/top-3-tech-stocks-which-could-rescue-your-portfolio-in-q4">Top 3 Tech Stocks Which Could Rescue Your Portfolio In Q4</a></li>
</ul>

BIDU

CLCO

KURA

PYXS

QUBT

SNOW

Nasdaq Edges Higher; Baidu Shares Fall After Q3 Results

Financial giants have made a conspicuous bullish move on SoFi Techs. Our analysis of options history for SoFi Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOFI#NASDAQ">SOFI</a>) revealed 33 unusual trades.
Delving into the details, we found 54% of traders were bullish, while 39% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $184,500, and 30 were calls, valued at $4,348,485.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $5.0 to $27.0 for SoFi Techs over the last 3 months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in SoFi Techs's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to SoFi Techs's substantial trades, within a strike price spectrum from $5.0 to $27.0 over the preceding 30 days.
<h3>SoFi Techs Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732217688_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SOFI</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$5.8</td>
<td>$5.7</td>
<td>$5.75</td>
<td>$12.00</td>
<td>$1.3M</td>
<td>39.6K</td>
<td>2.6K</td>
</tr>
<tr>
<td>SOFI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$4.75</td>
<td>$4.65</td>
<td>$4.64</td>
<td>$15.00</td>
<td>$469.4K</td>
<td>48.2K</td>
<td>6.5K</td>
</tr>
<tr>
<td>SOFI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$2.32</td>
<td>$2.3</td>
<td>$2.32</td>
<td>$15.00</td>
<td>$464.0K</td>
<td>22.5K</td>
<td>2.3K</td>
</tr>
<tr>
<td>SOFI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$4.6</td>
<td>$4.55</td>
<td>$4.56</td>
<td>$15.00</td>
<td>$412.4K</td>
<td>48.2K</td>
<td>6.5K</td>
</tr>
<tr>
<td>SOFI</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$8.75</td>
<td>$8.25</td>
<td>$8.75</td>
<td>$7.00</td>
<td>$168.8K</td>
<td>43.8K</td>
<td>694</td>
</tr>
</tbody>
</table>

<h3>About SoFi Techs</h3>
SoFi is a financial-services company that was founded in 2011 and is based in San Francisco. Initially known for its student loan refinancing business, the company has expanded its product offerings to include personal loans, credit cards, mortgages, investment accounts, banking services, and financial planning. The company intends to be a one-stop shop for its clients' finances and operates solely through its mobile app and website. Through its acquisition of Galileo in 2020, the company also offers payment and account services for debit cards and digital banking.
Having examined the options trading patterns of SoFi Techs, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Present Market Standing of SoFi Techs</h3>
<ul>
<li>Currently trading with a volume of 41,387,484, the SOFI's price is up by 4.98%, now at $15.4. </li>
<li>RSI readings suggest the stock is currently may be overbought.</li>
<li>Anticipated earnings release is in 67 days.</li>
</ul>
<h3>Professional Analyst Ratings for SoFi Techs</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $11.9.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Needham keeps a Buy rating on SoFi Techs with a target price of $13. 
&#x2A; An analyst from Goldman Sachs has decided to maintain their Neutral rating on SoFi Techs, which currently sits at a price target of $8. 
&#x2A; An analyst from Mizuho has decided to maintain their Outperform rating on SoFi Techs, which currently sits at a price target of $16. 
&#x2A; Maintaining their stance, an analyst from Barclays continues to hold a Equal-Weight rating for SoFi Techs, targeting a price of $9. 
&#x2A; Maintaining their stance, an analyst from Jefferies continues to hold a Buy rating for SoFi Techs, targeting a price of $13. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for SoFi Techs with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

SOFI

SoFi Techs Unusual Options Activity

Deep-pocketed investors have adopted a bullish approach towards Walt Disney (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in DIS usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 15 extraordinary options activities for Walt Disney. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 60% leaning bullish and 20% bearish. Among these notable options, 6 are puts, totaling $240,736, and 9 are calls, amounting to $439,043.
<h3>Projected Price Targets</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $95.0 to $125.0 for Walt Disney during the past quarter. 
<h3>Volume &amp; Open Interest Development</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Walt Disney's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Walt Disney's substantial trades, within a strike price spectrum from $95.0 to $125.0 over the preceding 30 days.
<h3>Walt Disney Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732217683_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>DIS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$6.75</td>
<td>$6.7</td>
<td>$6.7</td>
<td>$110.00</td>
<td>$76.3K</td>
<td>26.8K</td>
<td align="right">440</td>
</tr>
<tr>
<td>DIS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/06/24</td>
<td>$1.6</td>
<td>$1.6</td>
<td>$1.6</td>
<td>$115.00</td>
<td>$64.0K</td>
<td>2.8K</td>
<td align="right">426</td>
</tr>
<tr>
<td>DIS</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$15.45</td>
<td>$15.05</td>
<td>$15.22</td>
<td>$100.00</td>
<td>$60.8K</td>
<td>17.0K</td>
<td align="right">40</td>
</tr>
<tr>
<td>DIS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$7.55</td>
<td>$7.4</td>
<td>$7.52</td>
<td>$115.00</td>
<td>$59.4K</td>
<td>3.2K</td>
<td align="right">442</td>
</tr>
<tr>
<td>DIS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$6.75</td>
<td>$6.7</td>
<td>$6.7</td>
<td>$110.00</td>
<td>$47.5K</td>
<td>26.8K</td>
<td align="right">518</td>
</tr>
</tbody>
</table>

<h3>About Walt Disney</h3>
Disney operates in three global business segments: entertainment, sports, and experiences. Entertainment and experiences both benefit from the firm's ownership of iconic franchises and characters. Entertainment includes the ABC broadcast network, several cable television networks, and the Disney+ and Hulu streaming services. Within the segment, Disney also engages in movie and television production and distribution, with content licensed to movie theaters, other content providers, or, increasingly, kept in-house for use on Disney's own streaming platform and television networks. The sports segment houses ESPN and the ESPN+ streaming service. Experiences contains Disney's theme parks and vacation destinations, and also benefits from merchandise licensing.
<h3>Current Position of Walt Disney</h3>
<ul>
<li>With a volume of 6,075,759, the price of DIS is up 0.99% at $115.39. </li>
<li>RSI indicators hint that the underlying stock may be overbought.</li>
<li>Next earnings are expected to be released in 76 days.</li>
</ul>
<h3>What Analysts Are Saying About Walt Disney</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $129.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Deutsche Bank persists with their Buy rating on Walt Disney, maintaining a target price of $131. 
&#x2A; An analyst from B of A Securities has decided to maintain their Buy rating on Walt Disney, which currently sits at a price target of $140. 
&#x2A; An analyst from Evercore ISI Group has decided to maintain their Outperform rating on Walt Disney, which currently sits at a price target of $134. 
&#x2A; Reflecting concerns, an analyst from Needham lowers its rating to Buy with a new price target of $130. 
&#x2A; An analyst from Needham downgraded its action to Buy with a price target of $110. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Walt Disney, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Behind the Scenes of Walt Disney's Latest Options Trends

Deep-pocketed investors have adopted a bearish approach towards Futu Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FUTU#NASDAQ">FUTU</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in FUTU usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 11 extraordinary options activities for Futu Hldgs. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 27% leaning bullish and 63% bearish. Among these notable options, 7 are puts, totaling $521,498, and 4 are calls, amounting to $389,812.
<h3>What's The Price Target?</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $80.0 to $120.0 for Futu Hldgs over the recent three months. 
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Futu Hldgs's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Futu Hldgs's whale activity within a strike price range from $80.0 to $120.0 in the last 30 days. 
<h3>Futu Hldgs 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732217677_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>FUTU</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/22/24</td>
<td>$10.7</td>
<td>$9.8</td>
<td>$10.75</td>
<td>$95.00</td>
<td>$199.9K</td>
<td>1.7K</td>
<td>388</td>
</tr>
<tr>
<td>FUTU</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$0.98</td>
<td>$0.94</td>
<td>$0.98</td>
<td>$105.00</td>
<td>$166.9K</td>
<td>3.0K</td>
<td>2.1K</td>
</tr>
<tr>
<td>FUTU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$3.35</td>
<td>$3.1</td>
<td>$3.1</td>
<td>$100.00</td>
<td>$155.0K</td>
<td>2.4K</td>
<td>613</td>
</tr>
<tr>
<td>FUTU</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$16.0</td>
<td>$15.9</td>
<td>$16.0</td>
<td>$80.00</td>
<td>$80.0K</td>
<td>134</td>
<td>50</td>
</tr>
<tr>
<td>FUTU</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/22/24</td>
<td>$10.7</td>
<td>$9.8</td>
<td>$10.7</td>
<td>$95.00</td>
<td>$77.0K</td>
<td>1.7K</td>
<td>460</td>
</tr>
</tbody>
</table>

<h3>About Futu Hldgs</h3>
Futu Holdings Ltd is an online broker providing one-stop online investing services. The company provides its services through its digital platform Futu NiuNiu, which includes market data, trading service, and news feed of Hong Kong, Mainland China, Singapore, and United States equity markets. It generates its revenue in the form of brokerage commission and handling charge services.
<h3>Present Market Standing of Futu Hldgs</h3>
<ul>
<li>Currently trading with a volume of 2,164,151, the FUTU's price is down by -1.99%, now at $87.22. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 112 days.</li>
</ul>
<h3>What The Experts Say On Futu Hldgs</h3>
A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $95.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Reflecting concerns, an analyst from Citigroup lowers its rating to Neutral with a new price target of $95.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Futu Hldgs with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

FUTU

Futu Hldgs Unusual Options Activity

The explosive <a href="https://www.benzinga.com/etfs">growth of ETFs</a> is reshaping the financial landscape, with assets under management now nearing the $15 trillion mark. 
In a recent analysis, JPMorgan strategist Nikolaos Panigirtzoglou delves into the implications of this seismic shift, spotlighting how ETFs are redefining investor behavior, liquidity patterns, and even market risks. Here are his top 10 takeaways that every investor should know.
1. Retail Sentiment Is Driving Volatility Panigirtzoglou notes that the growing dominance of ETFs has made retail investors more influential in driving market sentiment. Unlike institutional investors, retail traders tend to have shorter time horizons, leading to sudden, amplified shifts in market trends when sentiment swings.
2. Longer Rallies, Sharper Corrections The analyst highlights how ETFs encourage momentum-driven markets, fueling prolonged rallies during bullish periods. However, during market reversals, the absence of active management safeguards can result in sharper corrections and increased volatility.
Read Also: <a href="https://www.benzinga.com/24/11/42097545/feds-bowman-warns-on-inflation-risks-signals-neutral-rate-may-be-closer">Fed&#8217;s Bowman Warns On Inflation, Says Neutral Interest Rates May Be Closer &#8216;Than We Currently Think&#8217;</a>
3. Big Money Flows Into Large-Caps Most ETFs are market-cap-weighted, which means they funnel disproportionate capital into large-cap stocks. Panigirtzoglou warns this trend could inflate valuations for mega-caps while crowding out smaller companies, risking capital misallocation.
Companies such as Nvidia Corp, Apple Inc, and Microsoft Corp each currently command over $3 trillion in market cap on the U.S. stock markets.
4. Liquidity Rushes to the Closing Bell As ETFs rebalance towards the end of trading sessions, liquidity has increasingly clustered during these periods. Around one-third of S&amp;P 500 trades now occur in the final 10 minutes of the day, Panigirtzoglou points out, creating a feedback loop of concentrated activity.
5. Concentrated Risks in a Few ETFs The rise of giant ETFs like the SPDR S&amp;P 500 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and the Invesco QQQ Trust, Series 1 ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) has introduced systemic risks. Panigirtzoglou argues that their scale and importance rival those of equity futures, making the market vulnerable to large, single-product flows.
6. Algorithmic Traders Are Thriving Bond ETFs, in particular, have bolstered electronic and algorithmic trading, says Panigirtzoglou. Non-bank market makers now dominate liquidity provision in fixed-income markets, capitalizing on high-volume, low-margin trades.
Popular bond ETFs, such as the iShares Core U.S. Aggregate Bond ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGG#NYSE">AGG</a>) and the Vanguard Total Bond Market ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BND#NYSE">BND</a>), are among the largest and most liquid bond market ETFs traded in the U.S.
7. Index Changes Have Outsized Effects Panigirtzoglou emphasizes how ETF-driven flows have magnified the impact of index rebalancing. Stocks entering major indices see outsized gains, while those removed face steeper declines than fundamentals might justify.
8. Corporate Governance Takes a Hit With passive funds dominating, Panigirtzoglou sees a decline in corporate activism. Unlike active managers, passive funds have little incentive to push for governance changes, which could diminish oversight.
9. Market Efficiency Is Declining The shift toward passive investing reduces opportunities for arbitrage, Panigirtzoglou argues, leading to more persistent mispricings. While this could lure active managers back, their ability to extract alpha has waned.
10. Passive Investing's Limit May Be Near Panigirtzoglou suggests there may be a natural ceiling for passive investing. If market inefficiencies grow too large, active managers could stage a comeback, attracting capital back from ETFs to actively managed funds.
The ETF revolution has undoubtedly democratized investing, but Panigirtzoglou warns that its rapid rise comes with unintended consequences. 
From concentrated liquidity to increased systemic risks, the landscape is evolving in ways that demand vigilance. 
As ETFs near the $15 trillion milestone, will passive dominance plateau, or is its impact just beginning?
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/24/11/42107863/us-futures-head-lower-as-nvidia-reports-slowdown-in-quarterly-revenue-growth-expert-says-market-weakness-is-perfectly-normal-but-late-november-is-still-possible">US Futures Head Lower As Nvidia Earnings Fail To Impress Investors: Expert Says Market Weakness Is &#8216;Perfectly Normal,&#8217; But Late November Rally Is Still Possible</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Analyst Color

Broad U.S. Equity ETFs

ETFs

10 Ways ETFs Are Reshaping US Markets As They Near $15 Trillion

Accenture (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACN#NYSE">ACN</a>) has acquired <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.awardsolutions.com%2Fportal%2F&amp;esheet=54156487&amp;newsitemid=20241121330816&amp;lan=en-US&amp;anchor=Award+Solutions&amp;index=1&amp;md5=ee80c80bea3cf769a6836c8c2dc6854b">Award Solutions</a>, a provider of training and consulting services in advanced wireless and network technologies, including 5G, internet of things, and cloud-based solutions. Terms of the transaction were not disclosed.
Established in 1997, Award Solutions is headquartered in Plano, Texas, and has employees based in Las Cruces, New Mexico; Branson, Missouri; San Diego, California; and Bangalore, India. The company offers specialized in-person, virtual, and self-paced training skills development programs to global telecom and technology providers, enabling them to leverage the latest technologies, such as 5G, artificial intelligence, automation, data visualization, machine learning, and network virtualization for the telecom industry. Award Solutions integrates the latest standards and technologies in its approach and has a proven track record of agile development to deliver customized, job relevant, network specific, real-world training that accelerates learning and skills acquisition which directly impact job performance. Through expert-led mentoring, Award Solutions equips its clients with the necessary skills to optimize their tech investments and enhance network performance.

Accenture Acquires Award Solutions To Expand Advanced Wireless Technologies Skills Training Content And Capabilities Of Accenture LearnVantage; Terms Of The Transaction Were Not Disclosed

Over half of the Magnificent 7 stocks have outperformed the S&amp;P 500 in 2024 and all seven have produced higher five-year returns. Benzinga readers pick which Magnificent 7 stock could have the best 2025 and if anyone can catch Nvidia Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), which continues to<a href="https://www.benzinga.com/news/earnings/24/11/42099904/nvidia-beats-q3-revenue-eps-estimates-supply-constraints-ding-stock-huang-says-age-of-ai-is-in-full-steam"> beat analyst estimates.</a>
What Happened: Nvidia stock is up 199% year-to-date in 2024 and could have more upside ahead according to <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/42119226/nvidia-analysts-see-stock-best-positioned-in-ai-not-worried-about-guidance-all-systems-go-for-blackwell-ramp">analyst price targets </a>after the company's third-quarter beat and raised guidance.
Benzinga recently asked readers if any of the <a href="https://www.benzinga.com/topic/magnificent-seven">Magnificent 7 stocks</a> could post stronger stock growth than Nvidia in the next year.
"In 2025, which Magnificent 7 stock could outpace Nvidia in growth?" Benzinga asked.
The results were:
<ul>
<li>None – Nvidia will dominate: 48%</li>
<li>Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>): 27%</li>
<li>Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>): 8%</li>
<li>Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>): 7%</li>
<li>Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>): 6%</li>
<li>Microsoft Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>): 3%</li>
<li>Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>): 2%</li>
</ul>
The poll found the near-majority predicting Nvidia will have the strongest growth in 2025 and dominate the Magnificent 7 stocks once again.
Coming in second place, and the stock that could have the best chance to pass Nvidia according to readers, was Tesla at 27%. This might not be a huge surprise given Tesla's five-year return is the next closest to Nvidia's when looking at the Magnificent 7 stocks.
Here are the current year-to-date and five-year returns of the Magnificent 7 stocks:
<ul>
<li>NVDA: YTD +199.1%, 5-Year +2,634.2%</li>
<li>TSLA: YTD +38.2%, 5-Year +1,446.2%</li>
<li>AMZN: YTD +31.3%, 5-Year +125.5%</li>
<li>META: YTD +61.3%, 5-Year +181.0%</li>
<li>GOOG: YTD +19.7%, 5-Year +158.0%</li>
<li>MSFT: YTD +11.4%, 5-Year +176.2%</li>
<li>AAPL: YTD +23.3%, 5-Year +249.7%</li>
</ul>
Perhaps most surprising in the poll was Apple finishing last despite having the third-best stock performance over the last five years.
Compare the returns above to the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>), which tracks the S&amp;P 500, which is up 25.3% year-to-date and up 90.4% over the last five years.
Meanwhile, the Roundhill Magnificent Seven ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAGS#NASDAQ">MAGS</a>), which invests in the Magnificent Seven stocks, is up 55.7% year-to-date. The ETF has not been around for five years to track that performance. 
Are you buying when the CEOs of the Magnificent 7 are selling?
<ul>
<li>Stay in the know with our Insider Trades page — <a href="https://www.benzinga.com/sec/insider-trades/">see when leaders like Mark Zuckerberg, Elon Musk, and Jensen Huang are offloading their own shares.</a></li>
</ul>
Why It's Important: A <a href="https://www.benzinga.com/tech/24/11/42093025/will-nvidia-deliver-a-blowout-beat-in-q3-poll-says-maybe-not-but-over-half-see-stock-clearing-150">recent Benzinga poll</a> asked readers to predict if Nvidia would beat, miss or meet earnings estimates in the third quarter.
The results were:
<ul>
<li>Meets expectations: 45%</li>
<li>Blowout Beat: 42%</li>
<li>Misses expectations: 13%</li>
</ul>
The majority of Benzinga readers expected the company to meet or beat the estimates from analysts. While more readers expected the company to meet estimates, 42% believed the company would beat estimates Wednesday.
Benzinga readers also predicted what an earnings beat could mean for Nvidia stock going forward.
&#8220;If Nvidia shatters expectations, how high could its stock go by the end of 2024?&#8221; Benzinga asked.
The results were:
<ul>
<li>$150 to $180: 55%</li>
<li>$180 to $200: 26%</li>
<li>Above $200: 18%</li>
</ul>
Nvidia shares traded down in after-hours Wednesday before reversing to the green in early Thursday trading. The stock is down 0.5% to $145.20 Thursday at the time of writing.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/top-stories/24/08/40602271/ready-to-retire-on-a-single-magnificent-7-stock-poll-reveals-top-pick-and-its-not-apple" target="_blank" rel="noreferrer noopener">Ready To Retire On A Single Magnificent 7 Stock? Poll Reveals Top Pick —And It's Not Apple</a></li>
</ul>
The study was conducted by Benzinga from Nov. 19 through Nov. 20, 2024, and included the responses of a diverse population of adults 18 or older. Opting into the survey was completely voluntary, with no incentives offered to potential respondents. The study reflects results from 128 adults.
Image: Unsplash

Exclusives

Tech

AAPL

AMZN

GOOG

GOOGL

MAGS

MSFT

NVDA

TSLA

Could Another Magnificent 7 Stock Beat Nvidia In 2025? Poll Says Not Likely, 27% Pick This Potential Winner

Offerings

PALI

Palisade Bio Offers Up To 2.06M Common Stock Shares At $2.43 Per Share

Spire Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SR#NYSE">SR</a>) reported a loss for the fourth <a href="https://www.benzinga.com/quote/SR/earnings">quarter on Wednesday</a>.
The company reported a quarterly loss of 54 cents per share, compared to market estimates of a loss of 52 cents per share. The company reported quarterly sales of $293.800 million which missed the analyst consensus estimate of $382.540 million.
&#8220;During fiscal 2024, despite the impacts of warm winter weather and rising interest expense, our team delivered solid financial and operating performance while providing affordable, reliable and safe energy to our customers,&#8221; said Steve Lindsey, president and chief executive officer of Spire. &#8220;Significant infrastructure investments and improved operational efficiency drove growth in our gas utilities during the year. In addition, Gas Marketing and Midstream continued to deliver solid results. We remain focused on continued execution of our strategy committed to capital-driven growth and operational excellence.&#8221;
Spire reaffirmed long-term adjusted EPS growth target of 5% to 7% and launched fiscal 2025 adjusted EPS guidance of $4.40 to $4.60.
Spire shares gained 2.9% to trade at $70.35 on Thursday.
These analysts made changes to their price targets on Spire following earnings announcement.
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5891df6243eaaa0001d69c76/sarah-akers">Wells Fargo analyst Sarah Akers</a> maintained Spire with an Equal-Weight and raised the price target from $73 to $75.</li>
<li>UBS analyst William Appicelli maintained the stock with a Buy and raised the price target from $75 to $80.</li>
</ul>
Considering buying SR stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="552" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21142223/image-230-1024x552.png" alt="" class="wp-image-659656" style="width:657px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21142223/image-230-1024x552.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21142223/image-230-300x162.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21142223/image-230-768x414.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21142223/image-230.png 1202w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/24/11/42117130/this-palo-alto-networks-analyst-turns-bullish-here-are-top-5-upgrades-for-thursday">This Palo Alto Networks Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday</a></li>
</ul>

Spire Analysts Boost Their Forecasts After Q4 Results

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Palantir Technologies (NYSE:<a href="https://investorplace.com/stock-quotes/pltr-stock-quote/">PLTR</a>) stock is in the news Wednesday after the big data company <a href="https://finance.yahoo.com/news/palantir-renews-digital-transformation-partnership-115900977.html">renewed a contract</a> with UniCredit.



According to a press release from Palantir, UniCredit has renewed its partnership with the company for another five years. That will see it make use of the Palantir Foundry operating system to enhance its digital transformation.



Investors will note that Palantir and UniCredit first started working together in 2018. Over those five years, UniCredit saw significant benefits from the Palantir Foundry operating system. That even resulted in it expanding the use of the technology to all CE&amp;EE UniCredit Legal Entities.



Josh Harris, a Palantir executive, said the following about this partnership.




&ldquo;Palantir has long been a proud partner to some of the world&rsquo;s top financial institutions. We&rsquo;re honored that UniCredit has placed its confidence in Palantir once again and look forward to furthering the bank&rsquo;s digital transformation.&rdquo;




<h2>PLTR Stock Movement on Wednesday</h2>



With this recent news comes some 7 million shares of PLTR stock changing hands. That&rsquo;s still a ways off from its daily average trading volume of about 61 million shares. The stock is also down 1.3% as of Wednesday morning despite the renewed contract. However, PLTR is up 170.4% year-to-date.



Investors looking for more of the latest stock market news will want to keep reading!



We have all of the hottest stock market news worth checking out on Wednesday! A few examples of that include what&rsquo;s happening with ReShape Lifesciences&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/rsls-stock-quote/">RSLS</a>), Pasithea Therapeutics&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/ktta-stock-quote/">KTTA</a>) and Loop Media&nbsp;(NYSEMKT:<a href="https://investorplace.com/stock-quotes/lptv-stock-quote/">LPTV</a>) stock. You can find more on these matters below!



<h2>More Wednesday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2023/12/why-is-reshape-lifesciences-rsls-stock-up-68-today/">Why Is ReShape Lifesciences (RSLS) Stock Up 68% Today?</a></li>



<li><a href="https://investorplace.com/2023/12/why-is-pasithea-therapeutics-ktta-stock-down-12-today/">Why Is Pasithea Therapeutics (KTTA) Stock Down 12% Today?</a></li>



<li><a href="https://investorplace.com/2023/12/why-is-loop-media-lptv-stock-down-16-today/">Why Is Loop Media (LPTV) Stock Down 16% Today?</a></li>
</ul>On the date of publication, William White&nbsp;did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771234">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771244">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/05/secret-income-blueprint-of-the-one-percent/?cid=MKT730394&amp;eid=MKT771242">The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2023/12/pltr-stock-palantir-renews-unicredit-partnership/">PLTR Stock: Palantir Renews UniCredit Partnership</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

PLTR Stock: Palantir Renews UniCredit Partnership

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Roblox (NYSE:<a href="https://investorplace.com/stock-quotes/rblx-stock-quote/">RBLX</a>) stock is on the move Wednesday as investors react to new coverage of the video game company&rsquo;s shares from Wells Fargo.



Wells Fargo analysts <a href="https://www.investing.com/news/stock-market-news/roblox-ads-to-become-significant-earnings-stream-over-time--wells-fargo-432SI-3255780">initiated coverage of RBLX stock</a> with an &ldquo;overweight&rdquo; rating. To put that in perspective, the analysts&rsquo; consensus rating for RBLX shares is moderate buy based on 22 opinions.



In addition to that, the company started its coverage of RBLX stock with a price target of $49 per share. That represents a potential upside of 16.6%. It&rsquo;s also bullish next to the analysts&rsquo; consensus price prediction of <a href="https://www.marketbeat.com/stocks/NYSE/RBLX/price-target/">$41.62 per share</a>.



<h2>Why the Bull Rating for RBLX Stock?</h2>



Here&rsquo;s what the Wells Fargo analysts had to say about Roblox in a note to clients obtained by Investing.com.




&ldquo;Similar to other audience platforms, we expect ads to become a significant earnings stream over time for Roblox, supported by strong user engagement. See meaningful upside to consensus bookings and EBITDA as we believe the ads opportunity is underappreciated by the Street, which has yet to properly capture future ad bookings into forecasts.&rdquo;




RBLX stock is up 2.5% as of Wednesday morning. This comes with more than 3.8 million shares traded. For the record, the company&rsquo;s daily average trading volume is still above that at 10.5 million shares.



Investors who want more of the latest stock market news are in luck!



We&rsquo;ve got all of the hottest stock market stories that traders need to know about on Wednesday! That includes everything going on with Palantir Technologies&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/pltr-stock-quote/">PLTR</a>) stock, ReShape Lifesciences&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/rsls-stock-quote/">RSLS</a>) stock and Pasithea Therapeutics&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/ktta-stock-quote/">KTTA</a>) stock. You can find out more on these matters at the following links!



<h2>More Wednesday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2023/12/pltr-stock-palantir-renews-unicredit-partnership/">PLTR Stock: Palantir Renews UniCredit Partnership</a></li>



<li><a href="https://investorplace.com/2023/12/why-is-reshape-lifesciences-rsls-stock-up-68-today/">Why Is ReShape Lifesciences (RSLS) Stock Up 68% Today?</a></li>



<li><a href="https://investorplace.com/2023/12/why-is-pasithea-therapeutics-ktta-stock-down-12-today/">Why Is Pasithea Therapeutics (KTTA) Stock Down 12% Today?</a></li>
</ul>On the date of publication, William White&nbsp;did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771234">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771244">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/05/secret-income-blueprint-of-the-one-percent/?cid=MKT730394&amp;eid=MKT771242">The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2023/12/rblx-stock-alert-wells-fargo-initiates-roblox-coverage-with-overweight-rating/">RBLX Stock Alert: Wells Fargo Initiates Roblox Coverage With &#8216;Overweight&#8217; Rating</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

RBLX Stock Alert: Wells Fargo Initiates Roblox Coverage With 'Overweight' Rating

Pasithea conducts 1-for-20 reverse stock split, gets FDA okay for study

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are worth checking out on Friday as we get into all of the biggest news affecting shares on the final day of trading this week!



Moving stocks today are public offerings, an earnings report and more.



Let&rsquo;s dive into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Aclarion (NASDAQ:<a href="https://investorplace.com/stock-quotes/acon-stock-quote/">ACON</a>) stock is rocketing more than 79% alongside heavy pre-market trading.</li>



<li>Himalaya Shipping (NYSE:<a href="https://investorplace.com/stock-quotes/hshp-stock-quote/">HSHP</a>) shares are soaring over 21% without any clear news this morning.</li>



<li>Ekso Bionics (NASDAQ:<a href="https://investorplace.com/stock-quotes/ekso-stock-quote/">EKSO</a>) stock is surging more than 20% with strong early morning trading.</li>



<li>Panbela Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/pbla-stock-quote/">PBLA</a>) shares are gaining over 19% as it prepares for a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318006293&amp;type=PDF&amp;symbol=PBLA&amp;cdn=255e23064a07775ab2cefc841a6dd3b1&amp;companyName=Panbela+Therapeutics+Inc.&amp;formType=S-1%2FA&amp;formDescription=%5BAmend%5D+General+form+for+registration+of+securities+under+the+Securities+Act+of+1933&amp;dateFiled=2024-01-25">proposed public offering</a>.</li>



<li>Ucommune International (NASDAQ:<a href="https://investorplace.com/stock-quotes/uk-stock-quote/">UK</a>) stock is increasing more than 18% on Friday morning.</li>



<li>The Real Brokerage (NASDAQ:<a href="https://investorplace.com/stock-quotes/reax-stock-quote/">REAX</a>) shares are rising over 18% after <a href="https://www.nasdaq.com/press-release/the-real-brokerage-invites-you-to-join-us-at-the-microcap-conference-2024-01-25">announcing a presentation next week</a>.</li>



<li>BIT Mining Limited (NYSE:<a href="https://investorplace.com/stock-quotes/btcm-stock-quote/">BTCM</a>) stock is climbing more than 16% on Friday.</li>



<li>Lixiang Education (NASDAQ:<a href="https://investorplace.com/stock-quotes/lxeh-stock-quote/">LXEH</a>) shares are getting an over 15% boost after <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318005286&amp;type=PDF&amp;symbol=LXEH&amp;cdn=6639882602bf7fce8ca884d95ec782b1&amp;companyName=Lixiang+Education+Holding+Co.+Ltd.&amp;formType=6-K&amp;formDescription=Report+of+foreign+private+issuer+pursuant+to+Rule+13a-16+or+15d-16+under+the+Securities+Exchange+Act+of+1934&amp;dateFiled=2024-01-25">regaining Nasdaq compliance</a>.</li>



<li>Porch Group (NASDAQ:<a href="https://investorplace.com/stock-quotes/prch-stock-quote/">PRCH</a>) stock is jumping more than 14% <a href="https://www.nasdaq.com/press-release/porch-group-receives-%2425m-with-signing-of-strategic-agreement-with-aon-2024-01-25">alongside a strategic agreement</a>.</li>



<li>Pasithea Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/ktta-stock-quote/">KTTA</a>) shares are up over 14% today.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Aptose Biosciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/apto-stock-quote/">APTO</a>) stock is plummeting more than 26% as <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318008758&amp;type=PDF&amp;symbol=APTO&amp;cdn=12b3da5a3896f2a507db32324ce6eb5a&amp;companyName=Aptose+Biosciences+Inc.&amp;formType=EFFECT&amp;formDescription=Notice+of+Effectiveness&amp;dateFiled=2024-01-25">a public offering goes into effect</a>.</li>



<li>SU Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SUGP#NASDAQ">SUGP</a>) shares are diving over 21% following its recent <a href="https://www.nasdaq.com/press-release/su-group-holdings-limited-announces-pricing-of-initial-public-offering-2024-01-23">initial public offering (IPO)</a>.</li>



<li>Eve&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/evex-stock-quote/">EVEX</a>) stock is tumbling more than 19% despite a lack of news.</li>



<li>Paramount Global (NASDAQ:<a href="https://investorplace.com/stock-quotes/para-stock-quote/">PARA</a>) shares are retreating over 18% after <a href="https://investorplace.com/2024/01/para-stock-alert-is-david-ellison-about-to-take-paramount-global-private/">rising yesterday on acquisition reports</a>.</li>



<li>LAVA Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/lvtx-stock-quote/">LVTX</a>) stock is taking a more than 12% beating <a href="https://www.marketwatch.com/story/lava-therapeutics-shares-rise-as-drug-set-for-test-with-merck-s-keytruda-c936d7cd">after rallying yesterday</a>.</li>



<li>Nxu (NASDAQ:<a href="https://investorplace.com/stock-quotes/nxu-stock-quote/">NXU</a>) shares are dropping over 12% after <a href="https://www.nasdaq.com/press-release/nxu-submits-for-nevi-grant-funding-to-enhance-its-major-highway-electrification-goals">seeking new grant funding</a>.</li>



<li>Sagimet Biosciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/sgmt-stock-quote/">SGMT</a>) stock is decreasing more than 11% with <a href="https://finance.yahoo.com/news/sagimet-biosciences-announces-proposed-public-224500288.html">public offering plans</a>.</li>



<li>Integrated Media Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/imte-stock-quote/">IMTE</a>) shares are falling over 11% on Friday.</li>



<li>Intel (NASDAQ:<a href="https://investorplace.com/stock-quotes/intc-stock-quote/">INTC</a>) stock is sliding more than 10% with <a href="https://www.cnbc.com/2024/01/25/intel-intc-earnings-report-q4-2023.html">Q4 earnings results</a>.</li>



<li>Clearmind Medicine (NASDAQ:<a href="https://investorplace.com/stock-quotes/cmnd-stock-quote/">CMND</a>) shares close out our pre-market stock movers down over 10%.</li>
</ol>On the date of publication, William White&nbsp;did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/01/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-friday-jan-26th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pasithea Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/ktta-stock-quote/">KTTA</a>) just reported results for the first quarter of 2024.<ul><li>Pasithea Therapeutics reported earnings per share of -$3.70.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/05/ktta-stock-earnings-pasithea-therapeutics-for-q1-of-2024/">KTTA Stock Earnings: Pasithea Therapeutics Reported Results for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

KTTA Stock Earnings: Pasithea Therapeutics Reported Results for Q1 2024

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pasithea Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/ktta-stock-quote/">KTTA</a>) just reported results for the fourth quarter of 2023.<ul><li>Pasithea Therapeutics reported earnings per share of -$4.10.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/06/ktta-stock-earnings-pasithea-therapeutics-for-q4-of-2023/">KTTA Stock Earnings: Pasithea Therapeutics Reported Results for Q4 2023</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

KTTA Stock Earnings: Pasithea Therapeutics Reported Results for Q4 2023

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pasithea Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/ktta-stock-quote/">KTTA</a>) just reported results for the second quarter of 2024.<ul><li>Pasithea Therapeutics reported earnings per share of -$3.71.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/ktta-stock-earnings-pasithea-therapeutics-for-q2-of-2024/">KTTA Stock Earnings: Pasithea Therapeutics Reported Results for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

KTTA Stock Earnings: Pasithea Therapeutics Reported Results for Q2 2024

Pasithea Therapeutics drops 19% on $5M private placement

Pasithea Therapeutics files to sell 3.74M shares of common stock for holders

Pasithea Therapeutics (KTTA) announced that the external Safety Review Committee, SRC, recommended proceeding to cohort 4, 15mg capsule, without mo...

Pasithea Therapeutics announces SRC recommended proceeding to cohort 4

ACON

APTO

BTCM

CMND

EKSO

EVEX

HSHP

IMTE

INTC

KTTAW

LPTV

LVTX

LXEH

PARA

PBLA

PLTR

PRCH

RBLX

REAX

RSLS

SGMT

SUGP

Press Releases

Pasithea Therapeutics Announces PAS-004 Abstract Accepted for Poster Presentation at 2024 ASCO Annual Meeting

Health Care

Pasithea Therapeutics to Present New Preclinical Data Showing PAS-004 Strongly Inhibits NRAS Cancer Cell Lines and Demonstrates Superior Activity in Xenograft Studies at 2024 ASCO Annual Meeting

Pasithea Therapeutics Announces Completion of Enrollment and Initial Dosing of Cohort 2 following Positive Safety Review Committee (SRC) Recommendation for PAS-004 in Ongoing Phase 1 Clinical Trial

Pasithea Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Pasithea Therapeutics Announces Appointment of Dr. Rebecca Brown to its Scientific Advisory Board

Pasithea Therapeutics Announces Successful Completion of PAS-004 Chronic Toxicity Studies

General

Pasithea Therapeutics Announces Positive Initial Safety, Tolerability, Pharmacokinetic (PK), and Preliminary Efficacy Data from its Phase 1 Clinical Trial of PAS-004 in Advanced Cancer

Technical Explosions: DUO, KTTA, TBIO, GOTU – Watch Peraso Inc. (NASDAQ: PRSO) Now Amid Breakout Momentum!

Pasithea Therapeutics Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Pasithea Therapeutics Announces Positive Safety Review Committee (SRC) Recommendation from its ongoing Phase 1 Clinical Trial of PAS-004 in Advanced Cancer

Comments

Pasithea Therapeutics

Pasithea Therapeutics (KTTA) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga